简
繁
EN
简
繁
EN
Home
Latest
Finance
IPO
ETF
Technology
Overseas
Research
HOME
·
CARSGEN-B
CARSGEN-B (02171.HK): Universal CAR-T product CT1190B receives NMPA IND approval for treatment of relapsed/refractory large B-cell lymphoma
Tags：
CARSGEN-B
02171.HK
R&D Progress
2026-08-07
CARsgen Therapeutics (02171.HK) CT041 Postoperative Adjuvant Therapy Study Results Accepted for ESMO 2026 Poster Presentation
Tags：
CARSGEN-B
02171.HK
biopharmaceutical
2026-07-15
CARSGEN-B(02171.HK): Kailimei® Secures NMPA Marketing Approval, the World’s First CAR-T Cell Therapy for Solid Tumors
Tags：
CARSGEN-B
02171.HK
New Drug Application
2026-06-22
CARSGEN-B (02171.HK) plans to issue up to 23.7 million shares by placement, with estimated net proceeds of HKD 461.96 million
Tags：
CARSGEN-B
02171.HK
Issue shares
2026-05-15
CARSGEN-B(02171.HK) closed 8.18% higher, The full-day turnover stood at HKD 190.55 million
Tags：
CARSGEN-B
02171.HK
NewTimeSpace
2026-05-07
Featured News
ETF
Chinaamc CSI 300 Index ETF (03188.HK) Rises 0.75% Intraday, Turnover Hits HK$64.2061 Million
ETF
iShares CSI 300 A-Share Index ETF (02846.HK) Rises 0.93% Intraday, AUM Stands at HK$5.43 Billion
ETF
CSOP Gold Futures Daily (2x) Leveraged Product (07299.HK) Rises 1.05% Intraday, Turnover Hits HK$13.6716 Million
ETF
Premia China STAR50 ETF (03151.HK) Gains 2.08% Intraday, NAV Per Unit at HK$12.026
ETF
Samsung S&P Gsci Crude Oil Er Futures Etf (03175.HK) Rises 3.51% Intraday at HK$9.59
Finance
Linmon Media Limited (09857.HK): Expected H1 Net Profit to Surge Around 77.7% to 255.4% Year-on-Year
Finance
Nuobikan Artificial Intelligence Technology (02635.HK): Signs RMB50.8 Million Software Sales Contract
Finance
Creality 3D Technology (03388.HK): Expected Loss of RMB53 Million–RMB63 Million for First Half
Finance
C C Land Holdings (01224.HK): Expected to Swing to Profit in First Half, Net Profit Around HK$30 Million
Finance
Sino Biopharmaceutical (01177.HK): Second-Generation Flurbiprofen Patch Approved for Marketing
Scan QR Code
Download App
